Treatment with an investigational oral inhibitor of Bruton's tyrosine kinase (BTK) was safe and boosted platelet counts in ...

Opportunistic acquisition adds Phase 2 novel checkpoint inhibitor (KVA12123) to TuHURA's late stage pipelineTargeting Phase 2a/b trial with ...

In the split second that is needed to view a stop sign and react to it, our brain navigates a complex process that transitions seamlessly from perception to action control. This ability to halt or ...

Cardiff Oncology’s investigational PLK1 inhibitor paired with standard-of-care treatment showed a 64% overall response rate ...

In the split second that is needed to view a stop sign and react to it, our brain navigates a complex process that ...

Learn how researchers measure and analyze the acoustic startle response in mice, a key method for studying neurological ...

Investigators were seeking clarification on optimal sequencing of the immune checkpoint inhibitor atezolizumab following ...

An investigational oral Janus kinase (JAK) inhibitor failed to meet most primary endpoints in a phase III trial of patients ...

Immune checkpoint inhibitors (ICI) have led to breakthrough improvements in the management of malignancy including hepatocellular (HCC) and biliary tract cancer, improving decades-old standards of ...

Scorpion Therapeutics, Inc. ("Scorpion"), a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer, today presented updated analyses from ...